Potassium Clavulanic Acid 50mg Injection

Get a Price/Quote

MOQ : 5000 Packs, ,

Potassium Clavulanic Acid 50mg Injection Specification

Usage
Used as a beta-lactamase inhibitor with antibiotics

Expiration Date
24 months from manufacturing date

Pacakaging (Quantity Per Box)
10 vials per box

Molecular Formula
C8H8KNO5

Appearance
White to off-white lyophilized powder

Indication
Treatment of infections caused by beta-lactamase producing bacteria

Dosage Form
Injection

Medicine Type
Allopathic

Origin of Medicine
India

Dosage
50mg/vial

Salt Composition
Potassium Clavulanate 50mg

CAS No
61177-45-5

Storage
Store below 25C, protected from light

Grade
Pharmaceutical Grade

Assay
Not less than 98% (on dried basis)

Potassium Clavulanic Acid 50mg Injection Trade Information

Minimum Order Quantity
5000 Packs, ,

FOB Port
Mumbai

Payment Terms
Cash in Advance (CID), Cash Advance (CA)

Supply Ability
100000 Packs, , UNITS Per Month

Delivery Time
45 to 60 days Days

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
AS PER BUYERS REQUIREMENT.

Main Export Market(s)
Australia, Western Europe, North America, South America, Middle East, Africa, Central America, Asia, Eastern Europe

Main Domestic Market
All India

Certifications
WHO GMP,ISO,FSSAI

About Potassium Clavulanic Acid 50mg Injection

Experience a prodigious leap in infection management with Potassium Clavulanic Acid 50mg Injection, offered at an unbeatable price for dealers, exporters, manufacturers, suppliers, and wholesalers across India. This acclaimed allopathic medicine acts as a pivotal beta-lactamase inhibitor, restoring the triumphant efficacy of antibiotics by inhibiting beta-lactamase enzymes. Freely soluble in water and presented as a white to off-white lyophilized powder in a sterile glass vial, each 50mg dose complies with Indian Pharmacopoeia standards. Redeem efficacy and peace of mindstore below 25C, safeguarded by premium USP Type I glass packaging, with a shelf life of 2 years.

Broad-Spectrum Applications in Diverse Healthcare Settings

Potassium Clavulanic Acid 50mg Injection is specifically designed for use in hospitals, clinics, and nursing homes where infections caused by beta-lactamase producing bacteria threaten patient outcomes. Applied intravenously or intramuscularly, it is commonly used on patients muscle tissue or through IV lines, providing crucial support in general and critical infection management. Its versatile surface application makes it indispensable for healthcare professionals handling diverse contamination scenarios.

Main Domestic & Export Markets with Flexible Payment Terms

Our main domestic market is India, supplying hospitals and healthcare providers with consistent drop-off and distribution. Internationally, we export to multiple regions, addressing global demand through a streamlined supply process. Proposal amounts can be tailored to dealer and wholesaler requirements, and payment terms remain versatile for both local and export transactions. We ensure reliable delivery, reinforcing our commitment to client satisfaction worldwide.

FAQs of Potassium Clavulanic Acid 50mg Injection:

Q: How does Potassium Clavulanic Acid 50mg Injection work to enhance antibiotic effectiveness?

A: Potassium Clavulanic Acid acts by inhibiting beta-lactamase enzymes produced by bacteria, thereby restoring and enhancing the efficacy of antibiotics against resistant infections.

Q: What storage conditions are recommended for maintaining its potency?

A: Stored below 25C and protected from light, the injections efficacy is preserved for its 2-year shelf life when maintained in its original glass vial packaging.

Q: When should this injection be administered and in what dosage?

A: Administer the injection intravenously or intramuscularly as prescribed by a healthcare professional, at the recommended dosage of 50mg per vial. Follow the reconstitution instructions on the label.

Q: Where can Potassium Clavulanic Acid 50mg Injection be used?

A: This injection is intended for use in professional healthcare settings such as hospitals, clinics, and nursing homes by trained medical personnel.

Q: What is the process for reconstituting the injection before administration?

A: Reconstitute the lyophilized powder with sterile water for injection according to the label guidelines, ensuring complete dissolution before administering to the patient.

Q: What are the benefits of choosing this product for infection control?

A: The primary benefits include reliable activity against beta-lactamase producing bacteria, compliance with Indian Pharmacopoeia standards, pharmaceutical grade quality, and availability at competitive prices for bulk buyers.

Tell us about your requirement